Literature DB >> 14719207

Clinical and genetic aspects of psoriatic arthritis "sine psoriasis".

Raffaele Scarpa1, Elena Cosentini, Francesco Manguso, Alfonso Oriente, Rosario Peluso, Mariangela Atteno, Fabio Ayala, Agesilao D'Arienzo, Pasquale Oriente.   

Abstract

OBJECTIVE: To characterize the clinical pattern of psoriatic arthritis (PsA) sine psoriasis.
METHODS: Fifty-seven patients (31 men, 26 women, mean age 46.32 +/- 14.12 yrs) with undifferentiated spondyloarthropathy (SpA) were studied. Two subsets were defined: (1) 21 patients with familial psoriasis (12 men, 9 women, mean age 49.29 +/- 14.17 yrs); (2) 36 patients without familial psoriasis (19 men, 17 women, mean age 44.58 +/- 14.00 yrs). The prevalence of the following clinical variables was evaluated: low back pain, enthesopathy, dactylitis, distal interphalangeal (DIP) arthritis, spinal involvement, and discitis. In all patients the following HLA haplotypes were tested: B7, B13, B17, B18, B27, B38, Cw6, and DR7.
RESULTS: Dactylitis and DIP arthritis were markedly present in the articular subset with familial psoriasis (p < 0.0001) that also showed a high frequency rate of HLA-Cw6 (p < 0.0001 vs controls and patients without familial psoriasis). HLA-B27 was markedly frequent in patients without familial psoriasis (p < 0.0001 vs controls and p = 0.019 vs patients with familial psoriasis). In addition, in patients with familial psoriasis the log-linear model showed that the presence of HLA-Cw6 was related to the presence of DIP arthritis as well as dactylitis (likelihood ratio chi-square change of 5.891 and p = 0.015).
CONCLUSION: A subset of patients with PsA "sine psoriasis" is identified by the occurrence of a SpA with dactylitis and/or DIP arthritis, presence of HLA-Cw6, and familial psoriasis in first or second-degree relatives.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14719207

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Psoriatic arthritis and psoriasis: differential diagnosis.

Authors:  Maddalena Napolitano; Francesco Caso; Raffaele Scarpa; Matteo Megna; Angela Patrì; Nicola Balato; Luisa Costa
Journal:  Clin Rheumatol       Date:  2016-05-07       Impact factor: 2.980

Review 2.  Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study.

Authors:  Francesco Caso; Antonio Del Puente; Francesca Oliviero; Rosario Peluso; Nicolò Girolimetto; Paolo Bottiglieri; Francesca Foglia; Carolina Benigno; Marco Tasso; Leonardo Punzi; Raffaele Scarpa; Luisa Costa
Journal:  Clin Rheumatol       Date:  2018-01-08       Impact factor: 2.980

Review 3.  [Outcome parameters for use in psoriatic arthritis].

Authors:  J Braun; S Wassenberg
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

Review 4.  Management of psoriatic arthritis from the view of the dermatologist.

Authors:  Caroline A Chang; Alice B Gottlieb; Paul F Lizzul
Journal:  Nat Rev Rheumatol       Date:  2011-09-13       Impact factor: 20.543

5.  Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA.

Authors:  Joseph F Merola; Vivian Herrera; Jacqueline B Palmer
Journal:  Clin Rheumatol       Date:  2018-07-26       Impact factor: 2.980

Review 6.  Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis.

Authors:  Sueli Carneiro; Penelope Esther Palominos; Sônia Maria Alvarenga Anti; Rodrigo Luppino Assad; Rafaela Silva Guimarães Gonçalves; Adriano Chiereghin; Andre Marun Lyrio; Antônio Carlos Ximenes; Carla Gonçalves Saad; Célio Roberto Gonçalves; Charles Lubianca Kohem; Cláudia Diniz Lopes Marques; Cláudia Goldenstein Schainberg; Eduardo de Souza Meirelles; Gustavo Gomes Resende; Lenise Brandao Pieruccetti; Mauro Waldemar Keiserman; Michel Alexandre Yazbek; Percival Degrava Sampaio-Barros; Ricardo da Cruz Lage; Rubens Bonfiglioli; Thauana Luíza Oliveira; Valderílio Feijó Azevedo; Washington Alves Bianchi; Wanderley Marques Bernardo; Ricardo Dos Santos Simões; Marcelo de Medeiros Pinheiro; Cristiano Barbosa Campanholo
Journal:  Adv Rheumatol       Date:  2021-11-24

7.  Extra-articular manifestations in psoriatic arthritis patients.

Authors:  Rosario Peluso; Salvatore Iervolino; Maria Vitiello; Vincenzo Bruner; Gelsy Lupoli; Matteo Nicola Dario Di Minno
Journal:  Clin Rheumatol       Date:  2014-05-08       Impact factor: 2.980

8.  The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate.

Authors:  Raffaele Scarpa; Rosario Peluso; Mariangela Atteno; Francesco Manguso; Angelo Spanò; Salvatore Iervolino; Matteo Nicola Dario Di Minno; Luisa Costa; Antonio Del Puente
Journal:  Clin Rheumatol       Date:  2007-11-21       Impact factor: 2.980

Review 9.  Optimal management of dactylitis in patients with psoriatic arthritis.

Authors:  Toshiyuki Yamamoto
Journal:  Open Access Rheumatol       Date:  2015-09-18

Review 10.  Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.

Authors:  Rosario Peluso; Giovanni Cafaro; Alessandro Di Minno; Salvatore Iervolino; Pasquale Ambrosino; Gelsy Lupoli; Matteo Nicola Dario Di Minno
Journal:  Clin Rheumatol       Date:  2013-04-16       Impact factor: 3.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.